Zhen Long , Dening Pei , Xiang Zhu , Weijing Liu , Xi Luo , Wenhong Fan , Lei Tao
{"title":"Characterizing recombinant protein and its fragmentation by top-down mass spectrometry","authors":"Zhen Long , Dening Pei , Xiang Zhu , Weijing Liu , Xi Luo , Wenhong Fan , Lei Tao","doi":"10.1016/j.jpba.2025.117157","DOIUrl":null,"url":null,"abstract":"<div><div>This study establishes a top-down mass spectrometry method for evaluating the structural integrity and fragmentation profiles of recombinant proteins. Three representative samples were analyzed: recombinant collagen 1 (RC1, 15.037 kDa; no disulfide bonds), recombinant collagen 2 (RC2, 49.859 kDa; no disulfide bonds), and interferon α2b (19.497 kDa; two disulfide bonds). Both targeted MS²-based, and data-dependent acquisition (DDA)-based top-down workflows were established to accommodate different analytical needs. The developed top-down strategies enabled direct sequencing of proteins with highly repetitive sequences, which pose challenges for bottom-up methods. The findings of this study provide insights into the identification of proteins with molecular weights (MWs) below 50 kDa. First, for proteins with MWs below 12 kDa, DDA-based top-down analysis utilizing HCD fragmentation provides high-throughput identification with 50 % (eg. of 27 fragments for protein RC1). Second, for proteins with MWs greater than 12 kDa, target-MS<sup>2</sup>-based top-down approaches improve sequence coverage, achieving up to 49.5 % for RC2 by combining three dissociation strategies. Third, for proteins containing disulfide bonds, disulfide reduce pretreatment prior to MS analysis is necessary to achieve improved residue cleavage coverage. Overall, this work demonstrates that top-down mass spectrometry provides complementary data to bottom-up methods, delivering crucial insights for comprehensive characterization of therapeutic recombinant proteins.</div></div>","PeriodicalId":16685,"journal":{"name":"Journal of pharmaceutical and biomedical analysis","volume":"267 ","pages":"Article 117157"},"PeriodicalIF":3.1000,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of pharmaceutical and biomedical analysis","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0731708525004984","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, ANALYTICAL","Score":null,"Total":0}
引用次数: 0
Abstract
This study establishes a top-down mass spectrometry method for evaluating the structural integrity and fragmentation profiles of recombinant proteins. Three representative samples were analyzed: recombinant collagen 1 (RC1, 15.037 kDa; no disulfide bonds), recombinant collagen 2 (RC2, 49.859 kDa; no disulfide bonds), and interferon α2b (19.497 kDa; two disulfide bonds). Both targeted MS²-based, and data-dependent acquisition (DDA)-based top-down workflows were established to accommodate different analytical needs. The developed top-down strategies enabled direct sequencing of proteins with highly repetitive sequences, which pose challenges for bottom-up methods. The findings of this study provide insights into the identification of proteins with molecular weights (MWs) below 50 kDa. First, for proteins with MWs below 12 kDa, DDA-based top-down analysis utilizing HCD fragmentation provides high-throughput identification with 50 % (eg. of 27 fragments for protein RC1). Second, for proteins with MWs greater than 12 kDa, target-MS2-based top-down approaches improve sequence coverage, achieving up to 49.5 % for RC2 by combining three dissociation strategies. Third, for proteins containing disulfide bonds, disulfide reduce pretreatment prior to MS analysis is necessary to achieve improved residue cleavage coverage. Overall, this work demonstrates that top-down mass spectrometry provides complementary data to bottom-up methods, delivering crucial insights for comprehensive characterization of therapeutic recombinant proteins.
期刊介绍:
This journal is an international medium directed towards the needs of academic, clinical, government and industrial analysis by publishing original research reports and critical reviews on pharmaceutical and biomedical analysis. It covers the interdisciplinary aspects of analysis in the pharmaceutical, biomedical and clinical sciences, including developments in analytical methodology, instrumentation, computation and interpretation. Submissions on novel applications focusing on drug purity and stability studies, pharmacokinetics, therapeutic monitoring, metabolic profiling; drug-related aspects of analytical biochemistry and forensic toxicology; quality assurance in the pharmaceutical industry are also welcome.
Studies from areas of well established and poorly selective methods, such as UV-VIS spectrophotometry (including derivative and multi-wavelength measurements), basic electroanalytical (potentiometric, polarographic and voltammetric) methods, fluorimetry, flow-injection analysis, etc. are accepted for publication in exceptional cases only, if a unique and substantial advantage over presently known systems is demonstrated. The same applies to the assay of simple drug formulations by any kind of methods and the determination of drugs in biological samples based merely on spiked samples. Drug purity/stability studies should contain information on the structure elucidation of the impurities/degradants.